Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1,376.90 Million | USD 2,764.48 Million | 8.20% | 2023 |
The global electromyography devices market size was worth around USD 1,376.90 million in 2023 and is predicted to grow to around USD 2,764.48 million by 2032, with a compound annual growth rate (CAGR) of roughly 8.20% between 2024 and 2032.
Electromyography (EMG) devices are designed to measure electrical activity or muscle response to a nerve’s stimulation of the muscle. EMG tests are used to detect neuromuscular abnormalities or conditions. The test consists of using one or more needles known as electrodes that are inserted into the muscle through the skin. The electrodes then pick up electrical activity displayed on a monitor known as an oscilloscope.
In addition, an audio amplifier is used to ensure that the electrical activity inside the body can be heard. EMG devices are used during forceful contraction, slight contracting, and resting phase of the muscles. In the absence of neuromuscular diseases, the body does not produce any form of electrical signals during the resting phase.
However, when the test is carried out, the medical professional may ask the patient to contract a muscle. The action potential is thus obtained and displayed on the oscilloscope, which provides insights into the muscle’s ability to respond to nerve stimulation. The applications of electromyography extend to additional sectors, such as the evaluation of muscle fitness of sports personnel.
Furthermore, it is also used in rehabilitation centers for patients undergoing physical therapy. During the forecast period, the market for EMG devices is expected to generate growth opportunities due to increasing innovation as well as rising end-user applications. However, the high cost of the devices and the lack of effective healthcare infrastructure may impact the industry’s final revenue.
Growing number of patients with neuromuscular disorders to drive market demand rate
The global electromyography devices market is expected to grow due to the rising number of patients suffering from several types of neuromuscular disorders. According to the Cleveland Clinic, neuromuscular disorders are caused by issues with the muscles, peripheral nerves, or the communication between these two body elements. Currently, thousands of neuromuscular disorders have been detected among the general population. One of the most common symptoms of neuromuscular disorder is muscle weakness, along with disturbance of sensation and muscle atrophy.
In addition to this, the conditions are classified into different groups depending on the dysfunction. These conditions affect different components of the neuromuscular system, such as peripheral nerves, anterior horn cells, muscle fibers, neuromuscular junction, plexuses, and nerve roots. Commonly reported neuromuscular conditions include multiple sclerosis, amyotrophic lateral sclerosis (ALS), myopathy, spinal muscular atrophy, myositis, and Charcot-Marie-Tooth disease, among others.
The growing prevalence of neuromuscular conditions across people of all age groups, genders, and ethnicities is expected to create demand for EGM devices. In addition to this, awareness surrounding neuromuscular disorders has improved in the last few years due to increased government initiatives and access to comprehensive information through the Internet.
Rising construction of new rehabilitation centers worldwide will create growth scope for the industry players
The revenue in the global electromyography devices market is expected to be further propelled by the rising construction of new rehabilitation centers worldwide. These facilities are specially designed to assist patients in recovering from major disabilities, surgical operations, or trauma.
Furthermore, they are equipped with advanced medical technologies essential for patient recovery. In October 2024, Narayan Medical College & Hospital (NMCH) in India announced the launch of Narayan Care. It is a center for advanced rehabilitation and education aimed at providing extensive care to children suffering from developmental and intellectual challenges.
High cost of the device and limited healthcare infrastructure limit the industry’s expansion rate
The global industry for electromyography devices is projected to be restricted due to the high cost of the device. The expenses associated with medical equipment increase with the introduction of more features of the tool and its overall offerings. For instance, the average cost of an intramuscular EMG device can range between USD 10,000 to USD 50,000.
Furthermore, the use of precision technology along with sophisticated data analysis programs leads to increased prices. The industry is also expected to be affected by the lack of sufficient healthcare infrastructure supporting investments in highly-priced medical devices.
Ongoing technological developments in the market to generate growth opportunities
The global electromyography devices market is expected to generate growth opportunities due to the rising rate of technological innovations. The introduction of new tools designed to manage the contemporary challenges of EGM development and application will be crucial to the industry’s growth rate in the future.
In October 2023, Rhythmlink International, LLC, a leading provider of high-grade medical equipment for neurodiagnostics, announced the expansion of its product portfolio. The company launched concentric needles designed for EMG-based studies. The needles are currently available in four sizes and offer options in terms of color, length, and diameter. Rhythmlink aims to assist medical practitioners in delivering better EMG-related medical care.
In May 2023, Cometa, another prominent provider of advanced EMG devices, announced the launch of a new range of EMG and inertial measurement unit (IMU) sensors. The product is called WaveX EMG offering unparalleled user experience. The wireless solution is equipped with fast memory download using Wi-Fi, 40 configurable analog outputs, and up to 36 channels simultaneously, among other features. In addition, market players are also focusing on developing more compact solutions without impacting output performance, which could create new waves of future growth.
Lack of skilled professionals in emerging economies to challenge market expansion
The global electromyography devices industry is expected to be challenged by the lack of skilled professionals, especially in emerging economies. The limited number of experts in terms of EMG device production and application results in fragmented growth. In addition to this, growing investments in the development of more affordable alternatives to EMG devices may dilute the overall revenue in the industry.
Report Attributes | Report Details |
---|---|
Report Name | Electromyography Devices Market |
Market Size in 2023 | USD 1,376.90 Million |
Market Forecast in 2032 | USD 2,764.48 Million |
Growth Rate | CAGR of 8.20% |
Number of Pages | 221 |
Key Companies Covered | ADInstruments, Natus Medical Incorporated, OT Bioelettronica, Allengers Medical Systems Limited, Neurosoft, Delsys Incorporated, Ambu AS, Clarity Medical, Nihon Kohden Corporation, Biometrics Ltd, Cadwell Industries Inc., A-M Systems LLC, Cometa Srl, iWorx, Noraxon USA Inc., and others. |
Segments Covered | By Modality, By End-User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global electromyography devices market is segmented based on modality, end-user, and region.
Based on modality, the global market segments are standalone and portable. In 2023, the highest growth was listed in the standalone segment. It dominated nearly 71.01% of the total market share. The growing applications of standalone EMG devices during essential paramedic situations as well as ambulatory services are aiding segmental demand. Growing awareness regarding neuromuscular diseases is projected to propel demand for portable and standalone systems.
Based on end-user, the electromyography devices industry divisions are rehabilitation centers, clinics, homecare centers, and hospitals. In 2023, the highest growth was listed in the hospitals segment. It held control over 42.05% of the final revenue. The growing investments in healthcare infrastructure worldwide, along with rising access to quality medical care, will promote growth in the hospital segment. In addition to this, rehabilitation centers are critical revenue generators for EMG devices.
North America to deliver the highest revenue during the forecast period
The global electromyography devices market will be led by North America during the forecast period. In 2023, the region dominated nearly 38.5% of the global market share. The presence of a robust and thriving healthcare industry across the US and Canada has been critical to the early adoption of advanced EMG devices across major medical care centers. Furthermore, the regional governments provide extensive healthcare policies covering the majority of the population in developed nations such as Canada.
According to the Centers for Disease Control and Prevention (CDC), US healthcare expenditure reported an increase of 7.5% in 2023, reaching up to USD 4.9 trillion. In addition to this, the presence of several key EMG device producers has helped the region deliver the most optimal results in the last few years.
In August 2023, Cadwell Industries, Inc., a US-based medical technology firm and provider of neuromonitoring solutions, announced the launch of MUS1™ neuromuscular ultrasound device for electrodiagnostic medical care. The company also launched the upgraded Sierra® 4 software for the Sierra Summit® device which works as an integration of EMG device clinical evoked potentials (EP), nerve conduction studies (NCS, and neuromuscular ultrasound (NMUS).
The global electromyography devices market is led by players like:
The global electromyography devices market is segmented as follows:
By Modality
By End-User
By Region
FrequentlyAsked Questions
Electromyography (EMG) devices are designed to measure electrical activity or muscle response to a nerve’s stimulation of the muscle.
The global electromyography devices market is expected to grow due to the rising number of patients suffering from several types of neuromuscular disorders.
According to study, the global electromyography devices market size was worth around USD 1,376.90 million in 2023 and is predicted to grow to around USD 2,764.48 million by 2032.
The CAGR value of the electromyography devices market is expected to be around 8.20% during 2024-2032.
The global electromyography devices market will be led by North America during the forecast period.
The global electromyography devices market is led by players like ADInstruments, Natus Medical Incorporated, OT Bioelettronica, Allengers Medical Systems Limited, Neurosoft, Delsys Incorporated, Ambu AS, Clarity Medical, Nihon Kohden Corporation, Biometrics Ltd, Cadwell Industries Inc., A-M Systems LLC, Cometa Srl, iWorx and Noraxon USA Inc.
The report explores crucial aspects of the electromyography devices market, including a detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed